While a link between headache medication and fracture healing has not been explored in sufficient detail before, our results indicate that the molecular targets of novel anti-migraine drugs, which inhibit CGRP or the CGRP receptor, also function as physiologic and anabolic mediators in bone regeneration. The gene discussed is CALCA; the disease is Headache.